CHICAGO, June 30, 2024 (GLOBE NEWSWIRE) — Vitamin K2 Market The Vitamin K2 market is projected to expand from USD 140 million in 2024 to USD 265 million in 2029, exhibiting a robust compound annual growth rate (CAGR) of 13.7% during the forecast period. Demand for Vitamin K2 supplements and fortified foods is growing as consumers prioritize preventive healthcare and seek natural alternatives. The nutrient’s role in activating a protein that binds calcium to bones and prevents it from accumulating in arteries has attracted attention from those concerned about cardiovascular and bone health.
Vitamin K2 plays a key role in bone health by activating proteins that help calcium uptake into bones, increasing bone strength and reducing the risk of fractures. According to the NIH (National Institutes of Health), 4 in 10 white women over 50 years of age in the United States may face a hip, spine, or wrist fracture, and vitamin K2 supplements can be a preventative measure to maintain bone health and minimize the risk of fractures.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=80962397
By product type, the MK-7 segment is expected to be the dominant product type during the forecast period.
MK-7 is a longer acting, more bioavailable form of vitamin K2, which has attracted significant attention due to its superior absorption and sustained effects in the body. This has led to its increased adoption in dietary supplements, fortified foods, and beverages, catering to the growing consumer demand for health and wellness products. Based on product type, the MK-7 segment is expected to be the leading product type during the forecast period. MK-7 is a longer acting, more bioavailable form of vitamin K2, which has attracted significant attention due to its superior absorption and sustained effects in the body. This has led to its increased adoption in dietary supplements, fortified foods, and beverages, catering to the growing consumer demand for health and wellness products.
Based on region, the United States dominates the vitamin K2 market in North America.
In the North American region, the United States has emerged as a major player in the Vitamin K2 market, contributing significantly to the overall market share. Several factors have contributed to this prominent position: Consumers are showing a strong interest in health and wellness, which is stimulating the demand for dietary supplements and fortified foods. Increased awareness of Vitamin K2’s benefits on bone and cardiovascular health is increasing the rate of consumer adoption.
Additionally, the rise in age-related health issues such as osteoporosis and cardiovascular diseases is also fueling the market growth. The aging population in the US is driving the demand for bone health supplements such as vitamin K2 to maintain overall health.
Key Market Players
- Gnosis by Lesaffre (NattoPharma) (France)
- Kappa Biosciences AS (Balchem Corporation) (USA)
- J-Oil Mills Co., Ltd. (Japan)
- Novozymes A/S (Denmark)
- BASF SE (Germany)
- Sangen Bioscience Co., Ltd. (China)
- Vesta Nutra (USA)
inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=80962397
Check out related reports:
Nutritional supplements market
Vitamin Market
